{"unnormalised": "AIIMS Delhi initiated a new clinical trial on 02/05/2024, evaluating the efficacy of immunotherapy for advanced stage lung cancer patients. Dr. Rajesh Kumar, Head of Oncology, mentioned the trial aims to improve survival rates, which currently stand at 15% for Stage IV lung cancer. The study involves 100 patients from across India.", "normalised": "A-I-I-M-S Delhi initiated a new clinical trial on second may two thousand and twenty four, evaluating the efficacy of immunotherapy for advanced stage lung cancer patients. Doctor Rajesh Kumar, Head of Oncology, mentioned the trial aims to improve survival rates, which currently stand at fifteen percent for Stage I-V lung cancer. The study involves one hundred patients from across India."}
{"unnormalised": "The trial utilizes a novel combination of Nivolumab and Ipilimumab, administered every 3 weeks. Patients undergo regular CT scans and blood tests to monitor treatment response and side effects. Early results are expected by Q4 2024.", "normalised": "The trial utilizes a novel combination of Nivolumab and Ipilimumab, administered every three weeks. Patients undergo regular C-T scans and blood tests to monitor treatment response and side effects. Early results are expected by Q four two thousand and twenty four."}
{"unnormalised": "Apollo Hospitals Chennai is also participating in a separate study focusing on targeted therapy for EGFR-mutated lung cancer. Prof. Meena Iyer, lead researcher, stated that the therapy aims to precisely target cancer cells, minimizing damage to healthy tissues. Patients receive Osimertinib 80mg daily.", "normalised": "Apollo Hospitals Chennai is also participating in a separate study focusing on targeted therapy for E-G-F-R-mutated lung cancer. Professor Meena Iyer, lead researcher, stated that the therapy aims to precisely target cancer cells, minimizing damage to healthy tissues. Patients receive Osimertinib eighty milligram daily."}
{"unnormalised": "This collaborative effort marks a significant step in advancing cancer treatment in India. The results from both trials are anticipated to influence future treatment guidelines and improve outcomes for cancer patients nationwide.", "normalised": "This collaborative effort marks a significant step in advancing cancer treatment in India. The results from both trials are anticipated to influence future treatment guidelines and improve outcomes for cancer patients nationwide."}
